RespireRx Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RSPI RespireRx Pharmaceuticals Inc
PPIH Perma-Pipe International Holdings Inc
PANL Pangaea Logistics Solutions Ltd
JAN Janone Inc
IMCC IM Cannabis Corp
FSNB Fusion Acquisition Corp II
SCPL Sciplay Corp
MKNGF Mkango Resources Ltd
CVX Chevron Corp
FDX FedEx Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

RespireRx Pharmaceuticals Inc. is engaged in the discovery and development of medicines for the treatment of psychiatric and neurological disorders. The Company is developing treatment options that address obstructive sleep apnea (OSA), attention deficit hyperactivity disorder (ADHD) epilepsy, chronic pain, including inflammatory and neuropathic pain, and recovery from spinal cord injury (SCI), which are conditions that affect people. It is developing a pipeline of new and re-purposed drug products based on its patent portfolios for two drug platforms: pharmaceutical cannabinoids platform, is developing compounds that target the body’s endocannabinoid system, and in particular, the re-purposing of dronabinol, an endocannabinoid CB1 and CB2 receptor agonist, for the treatment of obstructive sleep apnea (OSA) and neuromodulators platform includes AMPAkines that are positive allosteric modulators (PAMs) of AMPA-type glutamate receptors and GABAkines that are PAMs of GABAA receptors.

Closing Price
$0.0044
Day's Change
-0.0004 (-8.33%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0052
Day's Low
0.0044
Volume
(Light)
Volume:
238,500

10-day average volume:
1,131,869
238,500

Display:

Providers:

UpdateCancel
6 providers

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.